Discussion.

Open Access

Discussion.

Session: Lp(a): from causality to therapy

Topic: Lipid-Lowering Agents

Speaker: Professor E. Stroes (Amsterdam, NL) Professor P. Kamstrup (Copenhagen, DK) Professor F. Kronenberg (Innsbruck, AT)

Organised by PACE-CME - Supported by an unrestricted educational grant from Novartis, Sanofi, New Amsterdam & other sponsors

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speakers

Professor Erik Stroes

Academic Medical Centre, Amsterdam (Netherlands (The))

39 presentations

0 follower

Professor Pia Kamstrup

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

3 presentations

0 follower

Professor Florian Kronenberg

Medical University of Innsbruck, Innsbruck (Austria)

7 presentations

3 followers

3 more presentations in this session

Targeting Lp(a) in CV risk reduction: where are we now?

Speaker: Professor P. Kamstrup (Copenhagen, DK)

Access

Slides

Video

Lp(a) as independent causal risk factor: why should we focus on testing?

Speaker: Professor F. Kronenberg (Innsbruck, AT)

Access

Slides

Video

Targeting Lp(a): therapeutic insights and novel developments.

Speaker: Professor E. Stroes (Amsterdam, NL)

Access

Slides

Video

Access the full session

Lp(a): from causality to therapy

Speakers: Professor E. Stroes, Professor P. Kamstrup, Professor F. Kronenberg, Professor P. Kamstrup, Professor F. Kronenberg...

Access

Video

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources